We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QBE:ASXQBE Insurance Group Limited Analysis

Data as of 2026-03-10 - not real-time

A$20.78

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

QBE is trading at AUD 20.78, well below its DCF‑derived fair value of AUD 34.17, implying roughly a 12% upside. The stock’s PE of 10.2 is significantly lower than the industry average of 17.3, and it offers a strong dividend yield of 5.3% with a modest 42% payout ratio, underscoring cash‑flow robustness. Recent earnings beat – FY25 statutory profit of $2.16 bn and EPS of 2.03 – has sparked a short‑term price rally, yet technicals remain neutral: the 20‑day SMA sits just above price, MACD shows a bearish divergence and RSI hovers around 50.7. Liquidity is healthy with rising volume and ample support at AUD 19.33, while resistance near AUD 22.68 caps immediate upside.
Given its low beta (≈0.13‑0.30) and a 30% 30‑day volatility, QBE presents a defensive profile, though the insurance sector carries medium regulatory and geographic exposure across APAC and North America. The combination of undervaluation, solid profitability, and sustainable dividend makes the stock attractive for investors with a medium‑to‑long‑term horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat and dividend yield support price stability
  • Technical indicators (MACD bearish, RSI neutral) suggest limited near‑term upside
  • Proximity to support level at AUD 19.33 limits downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to DCF fair value and industry PE
  • Sustainable dividend and strong cash‑flow generation
  • Consistent profit growth and expanding gross written premium

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and defensive insurance business model
  • Robust balance sheet with manageable debt and high ROE
  • Attractive dividend yield and long‑term valuation gap

Key Metrics & Analysis

Financial Health

Profit Margin11.53%
P/E Ratio10.2
ROE19.33%
ROA4.20%
Debt/Equity33.67
P/B Ratio1.9
Op. Cash FlowA$4.2B
Free Cash FlowA$3.7B
Industry P/E17.3

Technical Analysis

TrendNeutral
RSI50.7
SupportA$19.33
ResistanceA$22.68
MA 20A$20.88
MA 50A$20.26
MA 200A$21.04
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair ValueA$34.17
Target PriceA$23.24
Upside/Downside11.85%
GradeUndervalued
TypeValue
Dividend Yield5.32%

Risk Assessment

Beta0.30
Volatility30.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.